Last reviewed · How we verify
Tranexamic 1 gram
At a glance
| Generic name | Tranexamic 1 gram |
|---|---|
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Tranexamic Acid for The Treatment of Gastrointestinal Bleeding (NA)
- Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction (PHASE4)
- The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients (PHASE2)
- Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children (PHASE3)
- Tranexamic Acid vs Vasopressin in Placenta Previa Trial (PHASE3)
- A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery (PHASE4)
- Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage (PHASE4)
- Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tranexamic 1 gram CI brief — competitive landscape report
- Tranexamic 1 gram updates RSS · CI watch RSS
- London School of Hygiene and Tropical Medicine portfolio CI